
AHA Hypertension 2020: New research suggests using automated office blood pressure monitoring is not the ideal way to determine a hypertension diagnosis.

AHA Hypertension 2020: New research suggests using automated office blood pressure monitoring is not the ideal way to determine a hypertension diagnosis.

AHA Hypertension 2020: Primary care practitioners rely on officed-based BP measures and outdated cut points to diagnose new hypertension.

A new research article found moderate and heavy alcohol intake were associated with hypertension in patients with type 2 diabetes.

The risk of having a CVD-related event is increased by 21% for every 1% increase in usual A1c >7% in patients with type 2 diabetes, a new study finds.

A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.

"Beyond hypertension, higher BPV is a major clinical predictor of cognitive impairment and dementia," conclude authors of a new study.

The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.

Refresh your memory on findings from the EMPA-REG OUTCOME, CANVAS, CREDENCE, and DECLARE-TIMI cardiovascular outcomes trials on SGLT2 inhibitors.

A new study found adults with high blood pressure were about half as likely to have serious cardiovascular events after receiving telemonitoring vs those receiving primary care.

In episode 2 of Primary Viewpoints, lipidologist and preventive cardiologist Seth Baum, MD, discusses lipid management in preventive cardiology.

Interview: The liver disease itself, and not the associated metabolic dysfunction, may lead to CV death in these patients. Seth Baum, MD, is involved in research for a treatment.

VIDEO: Preventive cardiology is a multidisciplinary therapeutic area and primary care clinicians have the advantage of greatest patient exposure to help advance care.

VIDEO: Treatment for ASCVD patients at high risk is lagging behind the availability of powerful new therapies. And, the pandemic does not help, according to Seth Baum, MD.

Palpitations and syncope during dinner (him); arrhythmia that looks like SVT after 2 energy drinks (her). What do the ECGs tell you?

Cardiologist Deepak Bhatt, MD, discusses factors to consider when assessing the need for cardiovascular risk management or reduction.

A key opinion leader discusses effective CV risk prevention measures, challenges to reducing adverse events, and effective patient education resources.

Deaths associated with atrial fibrillation have decreased, but it still takes an average of 2 years off a patient's life, according to a first-of-its-kind study.

This article reviews the evolving therapeutic landscape for lowering LDL-C and cardiovascular risk, with an emphasis on the role of omega-3 fatty acids.

Computer-interpreted ECGs are part of SOP -- but the interpretation still needs confirmatin. See if your ECG read matches the machine in 2 cases from the ED.

Fear of contracting COVID-19 would keep more than half of Hispanics and Blacks experiencing heart attack/stroke symptoms from going to a hospital.

Hypertension is the modifiable cardiovascular disease risk factor responsible for the greatest mortality. Test what you know about management.

Patients with hypertension are complex and pose a real challenge to primary care. Brigham and Women's cardiologist Dr Naomi Fisher offers history and highlights.

Preventive cardiology and lipid specialist Seth J. Baum, MD, answers questions about the state of preventive cardiology in the midst of COVID-19.

Try these 5 questions on patient CVD risk scenarios likely to present to primary care. Find out what you know about AHA/ACC guideline-recommended strategies.

VIDEO: Obesity is a chronic, relapsing disease that threatens to neutralize, even reverse, years of progress in reducing CVD-related death. Ted Kyle, RPh, explores.